Manufacturer record
A.S. Lifesciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by A.S. Lifesciences (Haryana) were declared Not of Standard Quality between July 2019 and November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: G4501, Mupikul Ointment (exp Sep 2025). DTL Chennai (state lab) found it not of standard quality: Sample does not conform to USP specification for Mupirocin Ointment with respect to the content of Mupirocin. Listed in the November 2024 alert.
Records by type
2 records linked to A.S. Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Mupikul Ointment | Batch G4501Mfg Oct 2023 · Exp Sep 2025 | Sample does not conform to USP specification for Mupirocin Ointment with respect to the content of Mupirocin.Other | DTL ChennaiState lab | Nov 2024 |
| Ewit-DSR Capsules (Esomeprazole- 40mg (E.C) & Domperidone 30 mg (SR) Capsules) | Batch C-6601Mfg Aug 2018 · Exp Jul 2020 | Dissolution for EsomeprazoleDissolution | CDTL MumbaiCDSCO lab | Jul 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.